Yu Shun Ting - Net Worth and Insider Trading
Yu Shun Ting Net Worth
The estimated net worth of Yu Shun Ting is at least $308,250 dollars as of 2024-12-15. Yu Shun Ting is the Director of China Resources Double-Crane Pharmaceutical Co Ltd and owns about 15,000 shares of China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) stock worth over $308,250. Details can be seen in Yu Shun Ting's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Yu Shun Ting has not made any transactions after 2022-12-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Yu Shun Ting
Yu Shun Ting Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Yu Shun Ting owns 1 companies in total, including China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) .
Click here to see the complete history of Yu Shun Ting’s form 4 insider trades.
Insider Ownership Summary of Yu Shun Ting
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SHSE:600062 | China Resources Double-Crane Pharmaceutical Co Ltd | 2022-12-20 | Director |
Yu Shun Ting Latest Holdings Summary
Yu Shun Ting currently owns a total of 1 stock. Yu Shun Ting owns 15,000 shares of China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) as of December 20, 2022, with a value of $308,250.
Latest Holdings of Yu Shun Ting
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SHSE:600062 | China Resources Double-Crane Pharmaceutical Co Ltd | 2022-12-20 | 15,000 | 20.55 | 308,250 |
Holding Weightings of Yu Shun Ting
Yu Shun Ting Form 4 Trading Tracker
According to the SEC Form 4 filings, Yu Shun Ting has made a total of 2 transactions in China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in China Resources Double-Crane Pharmaceutical Co Ltd is the acquisition of 5,000 shares on December 20, 2022, which cost Yu Shun Ting around $106,600.
Insider Trading History of Yu Shun Ting
- 1
Yu Shun Ting Trading Performance
GuruFocus tracks the stock performance after each of Yu Shun Ting's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Yu Shun Ting is -10.3%. GuruFocus also compares Yu Shun Ting's trading performance to market benchmark return within the same time period. The performance of stocks bought by Yu Shun Ting within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Yu Shun Ting's insider trading performs compared to the benchmark.
Performance of Yu Shun Ting
Yu Shun Ting Ownership Network
Ownership Network List of Yu Shun Ting
Ownership Network Relation of Yu Shun Ting
Yu Shun Ting Owned Company Details
What does China Resources Double-Crane Pharmaceutical Co Ltd do?
Who are the key executives at China Resources Double-Crane Pharmaceutical Co Ltd?
Yu Shun Ting is the Director of China Resources Double-Crane Pharmaceutical Co Ltd. Other key executives at China Resources Double-Crane Pharmaceutical Co Ltd include senior management han shuo , senior management Liu Zi Qin , and senior management Fan Yan Xi .
China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062)'s detailed insider trading history can be found in Insider Trading Tracker table.
China Resources Double-Crane Pharmaceutical Co Ltd Insider Transactions
Yu Shun Ting Mailing Address
Above is the net worth, insider trading, and ownership report for Yu Shun Ting. Currently GuruFocus does not have mailing address information for Yu Shun Ting.